NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

左心耳封閉 (LAAC) 設備的全球市場 - 市場規模·佔有率·COVID-19的影響分析 (2021年∼2027年) MedCore:心內膜設備市場,心外膜設備市場

Left Atrial Appendage Closure Device Market Size, Share & COVID-19 Impact Analysis | Global | 2021-2027 | MedCore | Segmented by: Endocardial Device Market and Epicardial Device Market

出版商 iData Research Inc. 商品編碼 1010041
出版日期 內容資訊 英文
商品交期: 最快1-2個工作天內
價格
左心耳封閉 (LAAC) 設備的全球市場 - 市場規模·佔有率·COVID-19的影響分析 (2021年∼2027年) MedCore:心內膜設備市場,心外膜設備市場 Left Atrial Appendage Closure Device Market Size, Share & COVID-19 Impact Analysis | Global | 2021-2027 | MedCore | Segmented by: Endocardial Device Market and Epicardial Device Market
出版日期: 2021年05月11日內容資訊: 英文
簡介

本報告提供70個國家以上的左心耳封閉 (LAAC) 設備企業相關相關調查分析,提供市場規模,銷售數量,平均銷售價格,企業的市場佔有率相關預測相關的系統性資訊。

全球左心耳封閉 (LAAC) 設備市場考察

全球左心耳封閉 (LAAC) 設備的市場規模到2027年將超過22億美元。

Boston Scientific,Abbott,AtriCure,是全球左心耳封閉 (LAAC) 設備市場佔有率領導者。

調查對象地區:

各地區的詳細內容,可作獨立報告購買。對象地區如下列。

  • 北美 (美國,加拿大)
  • 南美 (巴西,墨西哥,哥倫比亞,阿根廷,秘魯,智利,委內瑞拉,其他)
  • 西歐 (德國,法國,義大利,西班牙,瑞士,奧地利,葡萄牙,荷比盧三國,斯堪地那維亞,其他)
  • 中歐·東歐 (波蘭,土耳其,俄羅斯,希臘,捷克,克羅埃西亞,保加利亞,烏克蘭,哈薩克,匈牙利,羅馬尼亞,波羅的海三小國 (愛沙尼亞,拉脫維亞,立陶宛) 、其他)
  • 中東 (沙烏地阿拉伯,阿拉伯聯合大公國,以色列,伊朗,科威特,卡達,巴林,阿曼,其他)
  • 亞太地區 (中國,日本,韓國,印度,澳洲,新加坡,印尼,馬來西亞,泰國,菲律賓,汶萊,緬甸,柬埔寨,越南,紐西蘭,台灣,香港,其他)
  • 非洲 (南非,埃及,摩洛哥,迦納,奈及利亞,利比亞,蘇丹,烏干達,肯亞,其他)

對象的市場資料

  • 銷售數量,平均銷售價格,市場規模,成長趨勢
  • 治療數量
  • COVID-19的影響分析
  • 推動市場要素與阻礙要素
  • 到2017年∼2027年為止的市場實際成果資料與預測
  • 最近的合併和收購
  • 疾病概要
  • 主要的競爭企業的企業簡介,產品系列,SWOT

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: iDATA_GLCS21_MC_LAA

Throughout this medical market research, the publisher analyzed Left Atrial Appendage Closure Device companies across more than 70 countries and used their comprehensive methodology to understand the Market Sizes, Unit Sold, Average Selling Prices, Company Market Shares, and to create Accurate Forecasts.

Left Atrial Appendage Closure Device Market Insights

The global left atrial appendage closure device (LAA) market size is estimated to increase over the forecast period to exceed $2.2 billion by 2027.

Boston Scientific, Abbott, and AtriCure are the share leaders within the global left atrial appendage closure device market. The global analysis covers over 70 countries and includes the endocardial device market and the epicardial device market.

Left atrial appendage closure devices were developed as an alternative method of reducing the risk of stroke in atrial fibrillation patients. LAA closure devices are used to seal off the LAA, preventing clot formation in the LAA and eliminating the need for the patient to take blood-thinning medication. With the prevalence of atrial fibrillation increasing over the forecast period, competitors within the space are funding trials and studies proving the safety and effectiveness of their respective devices.

Research Regional Coverage

Throughout this research series, the publisher has covered several regions in great detail. Each region may be purchased as a stand-alone report, tailoring the data to your needs. The regions covered are:

  • North America (the United States and Canada)
  • Latin America (Brazil, Mexico, Colombia, Argentina, Peru, Chile, Venezuela, and Other)
  • Western Europe (Germany, France, Italy, Spain, Switzerland, Austria, Portugal, Benelux, Scandinavia, and Other)
  • Central and Eastern Europe (Poland, Turkey, Russia, Greece, Czech Republic, Croatia, Bulgaria, Ukraine, Kazakhstan, Hungary, Romania, Baltic States (Estonia, Latvia, and Lithuania), and Other)
  • Middle East (Saudi Arabia, UAE, Israel, Iran, Kuwait, Qatar, Bahrain, Oman, and Other)
  • Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Indonesia, Malaysia, Thailand, the Philippines, Brunei, Myanmar, Cambodia, Vietnam, New Zealand, Taiwan, Hong Kong, and Other)
  • Africa (South Africa, Egypt, Morocco, Ghana, Nigeria, Libya, Sudan, Uganda, Kenya, and Other)

MARKET DATA INCLUDED

  • Unit Sales, Average Selling Prices, Market Size & Growth Trends
  • Procedure Numbers
  • COVID-19 Impact Analysis
  • Market Drivers & Limiters
  • Market Forecasts Until 2027, and Historical Data to 2017
  • Recent Mergers & Acquisitions
  • Disease Overviews
  • Company Profiles, Product Portfolios, and SWOT for Top Competitors